Company: PTPI
Filing Date: 2025-03-18
Form Type: DEF 14A
Source: 0001104659-25-025104
Chunk: 107

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-03-18
Form: DEF 14A
Chunk 107
---
) months of the date the Board approved this Amendment, the additional shares added to the Plan pursuant to this Amendment
shall not be available for grant as Incentive Stock Options.

3. Except
as expressly amended by this Amendment, the Plan shall continue in full force and effect in accordance with the provisions thereof.

<div align='center'>[Signature page follows.]

D-1</div>

IN WITNESS WHEREOF,
the Company has caused this Amendment to be duly executed as of the date first written above.

| Petros Pharmaceuticals, Inc. |                                        |
| By:                          | /s/ Fady Boctor                        |
| Name:                        | Fady Boctor                            |
| Title:                       | President and Chief Commercial Officer |

<div align='center'>Signature Page to
First Amendment to Amended and Restated Petros Pharmaceuticals, Inc.
2020 Omnibus Incentive Compensation Plan

D-2</div>

ANNEX E

<div align='center'>Second AMENDMENT TO

Amended and restated Petros Pharmaceuticals, Inc.

2020 Omnibus Incentive Compensation PLAN</div>

Thissecond Amendment To amended and restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan(this “Amendment”), effective as of February 10, 2025
is made and entered into by Petros Pharmaceuticals, Inc., a Delaware corporation (the “Company”). Terms
used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms
in the Amended and Restated Petros Pharmaceuticals, Inc. 2020 Omnibus Incentive Compensation Plan (as amended prior to the date
hereof, the “Plan”).

<div align='center'>RECITALS</div>

WHEREAS,
Section 17(a) of the Plan provides that the Board of Directors of the Company (the “Board”) may amend
the Plan at any time and from time to time, provided that the Board shall not amend the Plan without stockholder approval if such approval
is required in order to comply with the Code or any other applicable law, or to comply with the applicable stock exchange requirements;
and

WHEREAS,
the Board desires to amend the Plan to revise the individual limits set forth in Section 4(d) of the Plan.

NOW, THEREFORE, in accordance with Section 17(a) of the Plan, the Company hereby amends the Plan as follows:

1. Section 4(d) of
the Plan is